Proud to see our Jersey specialist nurse-led cardiovascular prevention service presented at #BCS2026 Built from the ground up, the service brings proactive risk assessment, lifestyle medicine and coordinated follow-up into everyday cardiology care. Really encouraging early outcome data across multiple risk factors, highlighting the value of prevention-focused, multidisciplinary cardiac services. @BritishCardioSo @kirstieclutton @johnaaronhenry #prevention #JerseyHeartTeam

#SVTAwarenessDay highlights the importance of recognizing and managing rapid atrial arrhythmias in clinical practice. Improving awareness can help reduce delays in diagnosis and optimise treatment strategies. Explore resources: heartrhythmalliance.org/svt-… #WHRW2026

How Fast Are You Aging? New Genetic Clock May Have the Answer singularityhub.com/2026/06/0…

How will AI impact Jersey's workforce? Join Stephan Thoma to explore the roles most affected by AI and what leaders can do now to prepare. 📅 Tuesday 9th June | Book now: eu1.hubs.ly/H0vQPn80

Building an new era of health care with a focus on trust and hope jerseycardiologist.com/blog-… #health #trust #healthjersey

With effective therapies now available for HFpEF, timely identification matters. HFpEF remains complex and often underdiagnosed, even with normal LVEF, making it critical to recognize patterns that may otherwise be missed. At Ultromics, we are focused on supporting detection of complex cardiac diseases like HFpEF through routine echocardiography, helping clinicians uncover insights that can guide the next step in care. #HFpEF #HeartFailure #AIinCardiology #CardioTwitter

Teens' hearts tested after death of rugby player bbc.co.uk/news/articles/c2l2… #heartscreening #CPR #AED

It has been a remarkable two weeks for the Jersey Heart Team. Over the last fortnight, we have had a series of moments that feel genuinely important - not just for cardiology, but for the future of healthcare, research and innovation in Jersey. 🫀 First, we held our cardiology conference, “Matters of the Heart”, bringing together key stakeholders to help map out the next five years of cardiac services for the Island. The discussions were ambitious, practical and collaborative - exactly what is needed as we continue to build a service focused on prevention, early diagnosis, innovation, research and better outcomes for patients. 🏆 Second, we were delighted to see the Jersey Heart Team recognised through nominations in the Digital Jersey Tech Awards. This recognition reflects the extraordinary work of a whole team: clinicians, physiologists, nurses, administrators, digital partners, researchers and supporters who have helped make Jersey a place where health innovation can genuinely happen. 🔬 And finally, we received approval for IsleHFpEF - Jersey’s first Clinical Trial of an Investigational Medicinal Product, or CTIMP. This is a major milestone. It marks the beginning of a new chapter for clinical research in Jersey and, we hope, the start of a new medicines research industry for the Island. None of this happens by accident. It takes vision, persistence, governance, partnership and, most importantly, a team willing to keep pushing forward. I am incredibly proud of the Jersey Heart Team and grateful to all our colleagues, partners, patients, funders and supporters who are helping us turn ambition into reality. @jersey_research @DigitalJersey @JsyFoundation @UniofOxford #Cardiology #DigitalHealth #ClinicalResearch #Jersey #Innovation

🎟️ Tickets are now live for the 8th Annual Jersey TechAwards 🏆 Congratulations to everyone shortlisted across this year’s 13 categories 👏 👀 View the shortlist and book your tickets now: eu1.hubs.ly/H0vwWCS0

Ultromics’ AI supports early disease detection with strong peer-reviewed validation across HFpEF and cardiac amyloidosis. HFpEF → 90% sensitivity | 86% specificity Cardiac amyloidosis → 85% sensitivity | 93% specificity Learn more at ultromics.com/resources/the-… #CardioTwitter #ClinicalInnovation #ATTRCM #Amyloid #HFpEF #Cardiology

Really proud to see the Jersey Heart Team shortlisted in THREE categories at the Digital Jersey TechAwards 2026. 🏆 Leadership Award 🏆 Public & Third Sector Award 🏆 One To Watch Award Recognition for an incredible multidisciplinary team driving innovation in digital health, prevention, AI and cardiovascular research in Jersey. digital.je/jersey-techawards Huge thanks to collaborators across @DigitalJersey @GovJersey @GovJsyHCJ @jersey_research @JsyFoundation @UniofOxford and all our partners and supporters. Exciting times ahead… #DigitalHealth #HealthTech #Innovation #AI #Cardiology #Jersey

We are thrilled to announce that the 𝗞𝗮𝗿𝗱𝗶𝗮 𝟭𝟮𝗟 𝗘𝗖𝗚 𝗦𝘆𝘀𝘁𝗲𝗺 𝗵𝗮𝘀 𝗼𝗳𝗳𝗶𝗰𝗶𝗮𝗹𝗹𝘆 𝗿𝗲𝗰𝗲𝗶𝘃𝗲𝗱 𝗖𝗘 𝗠𝗮𝗿𝗸 (𝗖𝗼𝗻𝗳𝗼𝗿𝗺𝗶𝘁é 𝗘𝘂𝗿𝗼𝗽é𝗲𝗻𝗻𝗲) 𝗶𝗻 𝗘𝘂𝗿𝗼𝗽𝗲, putting hospital-grade diagnostic power into the hands of clinicians and improving access to high-quality cardiac care 🚀 🔗 Learn more: globenewswire.com/news-relea… #HealthTech #GlobalHealth #Kardia12L #MedTech #Cardiology #Innovation #EUHealth #EU

Good luck with the new programme. We found altered risk prediction in a half of patients. Published data: academic.oup.com/ehjimp/arti… and my early thoughts on how FAI changes practice here: jerseycardiologist.com/blog-…

Clinical Applications of Artificial Intelligence in Cardiovascular Imaging: Where Do We Stand?mdpi.com/2075-1729/16/3/507 #AI #imaging #cardiology @MDPIOpenAccess

I have been outspoken on the massive misuse of CAC testing for a long time (excerpt from my book in 2011) and have never ordered one.

Why is cardiology leading the AI revolution? It’s simple: Data. In a deep dive by @chrissyfarr and @MikhailAlexa, our CEO, Priya Abani, and Founder, @DrDave01, discuss why cardiology is the ultimate "data mine" for deep learning and how AliveCor is shifting the paradigm from reactive treatment to proactive prevention by making AI a seamless, trusted partner for clinicians in everyday diagnostics. 🔗Read the full analysis: secondopinion.media/p/if-you… #HealthTech #AI #Cardiology #digitalhealth #Innovation #AliveCor #FutureOfMedicine #medtechtwt

This is such a great project. Thanks to Impact.je for the financial support 🙏🏽 ☺️ #digitalhealth #JerseyHeartTeam

Delighted to have secured funding for the ISLE HFpEF trial - a double blind RCT of IV iron in HFpEF harnessing the power of wearable digital technologies to assess treatment response 🫀💉⌚️ @GovJsyHCJ @mitcharj @DigitalJersey